Stay updated on IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.

Latest updates to the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a completed study of indoximod combined with checkpoint inhibitors for metastatic melanoma, including its study details and posted results information.SummaryDifference61%

- Check14 days agoChange DetectedThe ClinicalTrials.gov page remains an error page showing “403 Forbidden,” while its footer revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAn NIH banner about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check42 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error with a simple header and a Home link, replacing the previous study content and indicating access to the page is blocked.SummaryDifference20%

- Check63 days agoChange DetectedThe page now shows revision v3.7.0, replacing the previous v3.6.6 to indicate an updated page version.SummaryDifference0.1%

Stay in the know with updates to IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.